Global Encephalitis Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Encephalitis Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Encephalitis Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Encephalitis Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Encephalitis Vaccine Segment by Type

2.2.1 Inactivated Vaccine

2.2.2 Live Attenuated Vaccine

2.3 Encephalitis Vaccine Sales by Type

2.3.1 Global Encephalitis Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Encephalitis Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Encephalitis Vaccine Sale Price by Type (2017-2022)

2.4 Encephalitis Vaccine Segment by Application

2.4.1 Child

2.4.2 Adult

2.5 Encephalitis Vaccine Sales by Application

2.5.1 Global Encephalitis Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Encephalitis Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Encephalitis Vaccine Sale Price by Application (2017-2022)

3 Global Encephalitis Vaccine by Company

3.1 Global Encephalitis Vaccine Breakdown Data by Company

3.1.1 Global Encephalitis Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Encephalitis Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Encephalitis Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Encephalitis Vaccine Revenue by Company (2020-2022)

3.2.2 Global Encephalitis Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Encephalitis Vaccine Sale Price by Company

3.4 Key Manufacturers Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Encephalitis Vaccine Product Location Distribution

3.4.2 Players Encephalitis Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Encephalitis Vaccine by Geographic Region

4.1 World Historic Encephalitis Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Encephalitis Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Encephalitis Vaccine Annual Revenue by Geographic Region

4.2 World Historic Encephalitis Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Encephalitis Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Encephalitis Vaccine Annual Revenue by Country/Region

4.3 Americas Encephalitis Vaccine Sales Growth

4.4 APAC Encephalitis Vaccine Sales Growth

4.5 Europe Encephalitis Vaccine Sales Growth

4.6 Middle East & Africa Encephalitis Vaccine Sales Growth

5 Americas

5.1 Americas Encephalitis Vaccine Sales by Country

5.1.1 Americas Encephalitis Vaccine Sales by Country (2017-2022)

5.1.2 Americas Encephalitis Vaccine Revenue by Country (2017-2022)

5.2 Americas Encephalitis Vaccine Sales by Type

5.3 Americas Encephalitis Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Encephalitis Vaccine Sales by Region

6.1.1 APAC Encephalitis Vaccine Sales by Region (2017-2022)

6.1.2 APAC Encephalitis Vaccine Revenue by Region (2017-2022)

6.2 APAC Encephalitis Vaccine Sales by Type

6.3 APAC Encephalitis Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Encephalitis Vaccine by Country

7.1.1 Europe Encephalitis Vaccine Sales by Country (2017-2022)

7.1.2 Europe Encephalitis Vaccine Revenue by Country (2017-2022)

7.2 Europe Encephalitis Vaccine Sales by Type

7.3 Europe Encephalitis Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Encephalitis Vaccine by Country

8.1.1 Middle East & Africa Encephalitis Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Encephalitis Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Encephalitis Vaccine Sales by Type

8.3 Middle East & Africa Encephalitis Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccine

10.3 Manufacturing Process Analysis of Encephalitis Vaccine

10.4 Industry Chain Structure of Encephalitis Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Encephalitis Vaccine Distributors

11.3 Encephalitis Vaccine Customer

12 World Forecast Review for Encephalitis Vaccine by Geographic Region

12.1 Global Encephalitis Vaccine Market Size Forecast by Region

12.1.1 Global Encephalitis Vaccine Forecast by Region (2023-2028)

12.1.2 Global Encephalitis Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Encephalitis Vaccine Forecast by Type

12.7 Global Encephalitis Vaccine Forecast by Application

13 Key Players Analysis

13.1 Valneva

13.1.1 Valneva Company Information

13.1.2 Valneva Encephalitis Vaccine Product Offered

13.1.3 Valneva Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Valneva Main Business Overview

13.1.5 Valneva Latest Developments

13.2 Sanofi Pasteur

13.2.1 Sanofi Pasteur Company Information

13.2.2 Sanofi Pasteur Encephalitis Vaccine Product Offered

13.2.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Pasteur Main Business Overview

13.2.5 Sanofi Pasteur Latest Developments

13.3 Biken

13.3.1 Biken Company Information

13.3.2 Biken Encephalitis Vaccine Product Offered

13.3.3 Biken Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biken Main Business Overview

13.3.5 Biken Latest Developments

13.4 Wuhan Institute of Biological Products

13.4.1 Wuhan Institute of Biological Products Company Information

13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccine Product Offered

13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Wuhan Institute of Biological Products Main Business Overview

13.4.5 Wuhan Institute of Biological Products Latest Developments

13.5 Lanzhou Institute of Biological Products

13.5.1 Lanzhou Institute of Biological Products Company Information

13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Offered

13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lanzhou Institute of Biological Products Main Business Overview

13.5.5 Lanzhou Institute of Biological Products Latest Developments

13.6 Chengdu Institute of Biological Products

13.6.1 Chengdu Institute of Biological Products Company Information

13.6.2 Chengdu Institute of Biological Products Encephalitis Vaccine Product Offered

13.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Chengdu Institute of Biological Products Main Business Overview

13.6.5 Chengdu Institute of Biological Products Latest Developments

13.7 Tiantan Biological Products

13.7.1 Tiantan Biological Products Company Information

13.7.2 Tiantan Biological Products Encephalitis Vaccine Product Offered

13.7.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Tiantan Biological Products Main Business Overview

13.7.5 Tiantan Biological Products Latest Developments

13.8 Liaoning Chengda

13.8.1 Liaoning Chengda Company Information

13.8.2 Liaoning Chengda Encephalitis Vaccine Product Offered

13.8.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Liaoning Chengda Main Business Overview

13.8.5 Liaoning Chengda Latest Developments

13.9 Zhejiang Tianyuan Bio-Pharmaceutical

13.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information

13.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Offered

13.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview

13.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments

13.10 Yisheng Bio

13.10.1 Yisheng Bio Company Information

13.10.2 Yisheng Bio Encephalitis Vaccine Product Offered

13.10.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Yisheng Bio Main Business Overview

13.10.5 Yisheng Bio Latest Developments

13.11 Changchun Institute of Biological Products

13.11.1 Changchun Institute of Biological Products Company Information

13.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Product Offered

13.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Changchun Institute of Biological Products Main Business Overview

13.11.5 Changchun Institute of Biological Products Latest Developments

14 Research Findings and Conclusion

Table 1. Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Encephalitis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Inactivated Vaccine

Table 4. Major Players of Live Attenuated Vaccine

Table 5. Global Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 6. Global Encephalitis Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Encephalitis Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Encephalitis Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Encephalitis Vaccine Sale Price by Type (2017-2022) & (USD/Dose)

Table 10. Global Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 11. Global Encephalitis Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Encephalitis Vaccine Revenue by Application (2017-2022)

Table 13. Global Encephalitis Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Encephalitis Vaccine Sale Price by Application (2017-2022) & (USD/Dose)

Table 15. Global Encephalitis Vaccine Sales by Company (2020-2022) & (M Doses)

Table 16. Global Encephalitis Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Encephalitis Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Encephalitis Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Encephalitis Vaccine Sale Price by Company (2020-2022) & (USD/Dose)

Table 20. Key Manufacturers Encephalitis Vaccine Producing Area Distribution and Sales Area

Table 21. Players Encephalitis Vaccine Products Offered

Table 22. Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Encephalitis Vaccine Sales by Geographic Region (2017-2022) & (M Doses)

Table 26. Global Encephalitis Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Encephalitis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Encephalitis Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Encephalitis Vaccine Sales by Country/Region (2017-2022) & (M Doses)

Table 30. Global Encephalitis Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Encephalitis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Encephalitis Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)

Table 34. Americas Encephalitis Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Encephalitis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Encephalitis Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 38. Americas Encephalitis Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 40. Americas Encephalitis Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Encephalitis Vaccine Sales by Region (2017-2022) & (M Doses)

Table 42. APAC Encephalitis Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Encephalitis Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Encephalitis Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 46. APAC Encephalitis Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 48. APAC Encephalitis Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)

Table 50. Europe Encephalitis Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Encephalitis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Encephalitis Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 54. Europe Encephalitis Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 56. Europe Encephalitis Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Encephalitis Vaccine Sales by Country (2017-2022) & (M Doses)

Table 58. Middle East & Africa Encephalitis Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Encephalitis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Encephalitis Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Encephalitis Vaccine Sales by Type (2017-2022) & (M Doses)

Table 62. Middle East & Africa Encephalitis Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Encephalitis Vaccine Sales by Application (2017-2022) & (M Doses)

Table 64. Middle East & Africa Encephalitis Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Encephalitis Vaccine

Table 66. Key Market Challenges & Risks of Encephalitis Vaccine

Table 67. Key Industry Trends of Encephalitis Vaccine

Table 68. Encephalitis Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Encephalitis Vaccine Distributors List

Table 71. Encephalitis Vaccine Customer List

Table 72. Global Encephalitis Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 73. Global Encephalitis Vaccine Sales Market Forecast by Region

Table 74. Global Encephalitis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Encephalitis Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Encephalitis Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 77. Americas Encephalitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Encephalitis Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 79. APAC Encephalitis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Encephalitis Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 81. Europe Encephalitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Encephalitis Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 83. Middle East & Africa Encephalitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Encephalitis Vaccine Sales Forecast by Type (2023-2028) & (M Doses)

Table 85. Global Encephalitis Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Encephalitis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Encephalitis Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Encephalitis Vaccine Sales Forecast by Application (2023-2028) & (M Doses)

Table 89. Global Encephalitis Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Encephalitis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Encephalitis Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Valneva Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Valneva Encephalitis Vaccine Product Offered

Table 94. Valneva Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 95. Valneva Main Business

Table 96. Valneva Latest Developments

Table 97. Sanofi Pasteur Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofi Pasteur Encephalitis Vaccine Product Offered

Table 99. Sanofi Pasteur Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 100. Sanofi Pasteur Main Business

Table 101. Sanofi Pasteur Latest Developments

Table 102. Biken Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Biken Encephalitis Vaccine Product Offered

Table 104. Biken Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 105. Biken Main Business

Table 106. Biken Latest Developments

Table 107. Wuhan Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Wuhan Institute of Biological Products Encephalitis Vaccine Product Offered

Table 109. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 110. Wuhan Institute of Biological Products Main Business

Table 111. Wuhan Institute of Biological Products Latest Developments

Table 112. Lanzhou Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Offered

Table 114. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 115. Lanzhou Institute of Biological Products Main Business

Table 116. Lanzhou Institute of Biological Products Latest Developments

Table 117. Chengdu Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Chengdu Institute of Biological Products Encephalitis Vaccine Product Offered

Table 119. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 120. Chengdu Institute of Biological Products Main Business

Table 121. Chengdu Institute of Biological Products Latest Developments

Table 122. Tiantan Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Tiantan Biological Products Encephalitis Vaccine Product Offered

Table 124. Tiantan Biological Products Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 125. Tiantan Biological Products Main Business

Table 126. Tiantan Biological Products Latest Developments

Table 127. Liaoning Chengda Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Liaoning Chengda Encephalitis Vaccine Product Offered

Table 129. Liaoning Chengda Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 130. Liaoning Chengda Main Business

Table 131. Liaoning Chengda Latest Developments

Table 132. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Offered

Table 134. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 135. Zhejiang Tianyuan Bio-Pharmaceutical Main Business

Table 136. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments

Table 137. Yisheng Bio Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Yisheng Bio Encephalitis Vaccine Product Offered

Table 139. Yisheng Bio Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 140. Yisheng Bio Main Business

Table 141. Yisheng Bio Latest Developments

Table 142. Changchun Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. Changchun Institute of Biological Products Encephalitis Vaccine Product Offered

Table 144. Changchun Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 145. Changchun Institute of Biological Products Main Business

Table 146. Changchun Institute of Biological Products Latest Developments

List of Figures

Figure 1. Picture of Encephalitis Vaccine

Figure 2. Encephalitis Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Encephalitis Vaccine Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Encephalitis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Encephalitis Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Inactivated Vaccine

Figure 10. Product Picture of Live Attenuated Vaccine

Figure 11. Global Encephalitis Vaccine Sales Market Share by Type in 2021

Figure 12. Global Encephalitis Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Encephalitis Vaccine Consumed in Child

Figure 14. Global Encephalitis Vaccine Market: Child (2017-2022) & (M Doses)

Figure 15. Encephalitis Vaccine Consumed in Adult

Figure 16. Global Encephalitis Vaccine Market: Adult (2017-2022) & (M Doses)

Figure 17. Global Encephalitis Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Encephalitis Vaccine Revenue Market Share by Application in 2021

Figure 19. Encephalitis Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Encephalitis Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Encephalitis Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Encephalitis Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Encephalitis Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Encephalitis Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Encephalitis Vaccine Sales 2017-2022 (M Doses)

Figure 26. Americas Encephalitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Encephalitis Vaccine Sales 2017-2022 (M Doses)

Figure 28. APAC Encephalitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Encephalitis Vaccine Sales 2017-2022 (M Doses)

Figure 30. Europe Encephalitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Encephalitis Vaccine Sales 2017-2022 (M Doses)

Figure 32. Middle East & Africa Encephalitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Encephalitis Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Encephalitis Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Encephalitis Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Encephalitis Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Encephalitis Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Encephalitis Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Encephalitis Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Encephalitis Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Encephalitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Encephalitis Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Encephalitis Vaccine

Figure 63. Industry Chain Structure of Encephalitis Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles